Healthcare -
Biotechnology - NASDAQ - CH
$ 5.03
10.1 %
$ 185 M
Market Cap
-2.38
P/E
MOLN - COST OF REVENUE
Cost of Revenue MOLN - Molecular Partners AG
47.8 M
LAST VALUE
-7.33%
2 YEAR CAGR
25.12%
5 YEAR CAGR
44.32%
10 YEAR CAGR